Eamonn Hobbs Appointed President & CEO of Delcath Systems (DCTH)
More News related to ANGO
- AngioDynamics Appoints Stephen McGill as Senior Vice President and General Manager, International
- AngioDynamics (ANGO) Tops Q1 Views; Raises FY10 Outlook
- AngioDynamics Reports Fiscal First Quarter 2010 Financial Results
- Trading Radar for 10/06: Yum! (YUM), Pepsi Bottling (PBG), Chattem (CHTT), AngioDynamics (ANGO) Report
- Beacon Equity Issues Trading Outlook for BSD Medical Corp.
More News related to DCTH
- Delcath Systems (DCTH) Announces 8.5M Common Stock Offering
- Delcath Systems, Inc. Announces Public Offering of Common Stock
- Delcath Systems Completes Executive Management Team with Strategic New Hires
- Delcath Systems (DCTH) Announces Phase III Melanoma Study Fully Enrolled
- Delcath Systems, Inc. Completes Phase III Study Enrollment
Delcath Systems, Inc. (Nasdaq: DCTH) announced that Eamonn P. Hobbs, 51, a member of the Delcath Board of Directors since October 2008, has been appointed President and CEO of the Company. Mr. Hobbs succeeds Richard Taney who has led the company since December 2006 and will continue to serve on the Company's Board of Directors.
Mr. Hobbs has over 25 years of experience in the interventional radiology, interventional cardiology and gastroenterology medical device industries. From 1988 until earlier this year, Mr. Hobbs was President and CEO of AngioDynamics, Inc. (Nasdaq: ANGO).
Related Categories
Corporate NewsManagement Changes
Stocks Mentioned
-0.29Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
